Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting

Friday, February 1, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

WESTFORD, Mass., Jan. 31 Cynosure, Inc.(Nasdaq: CYNO), a leading developer and manufacturer of a broad array oflight-based aesthetic treatment systems, today announced the introduction ofthree aesthetic products for fast-growing applications including laserlipolysis, the removal of pigmented lesions and ablative skin resurfacing.Cynosure will showcase its new products, SmartSense(TM) for Smartlipo(TM),Accolade(TM) and Affirm Er, at the American Academy of Dermatology (AAD) 2008Annual Meeting, which kicks off tomorrow in San Antonio, Texas.

"Cynosure's strategic vision is centered on the continuous improvement ofaesthetic procedures through technology innovations that benefit patients andpractitioners," said Michael Davin, Cynosure's president and chief executiveofficer. "Each of the products we are launching today fulfills that mission.Accolade, the sixth flagship product we have introduced in the past fouryears, creates exciting new revenue opportunities for us, particularly inmarkets throughout Asia, while SmartSense and Affirm Er enhance the benefitsand performance of our two most recently introduced workstations."

SmartSense for Smartlipo -- Delivering Precise Energy Control toLaserBodySculpting

Recently FDA cleared, SmartSense is a proprietary intelligent handpiecedelivery system for Smartlipo, Cynosure's ground-breaking, minimally invasivesystem that liquefies and removes localized deposits of fat and results intissue tightening through tissue coagulation. SmartSense features an advancedmicrochip, the Accelerometer, which is inserted into the intelligenthandpiece, to ensure the precise level of energy is delivered based on thearea of treatment and predetermined settings in conjunction with the motion ofthe handpiece.

"SmartSense provides our customers with an unparalleled degree of safety,precision and control that is not available with any other laser lipolysistechnology," Davin said. "Based on the setting you choose and the motion ofthe handpiece, SmartSense provides aesthetic surgeons with the precise laserpower to perform laser lipolysis. To provide the maximum level of patientsafety, if handpiece motion ceases SmartSense will stop the laser from firing,but remains ready and resumes firing once the handpiece is set in motionagain."

"SmartSense is an excellent addition to the Smartlipo workstation becauseit allows me to tailor the level of energy to the demands of the specificclinical indication," said Barry Di Bernardo, M.D., medical director of NewJersey Plastic Surgery. "This not only helps to achieve a more consistentclinical outcome, but also adds an extra layer of safety and piece of mind formy patients. I look forward to incorporating the SmartSense into my laserlipolysis practice."

Accolade -- State-of-the-Art Technology to Remove Pigmented Lesions

Accolade is a high powered 755 nm, Q-switched Alexandrite laser for theremoval of pigmented lesions. The unique combination of various spot sizesand the laser's high repetition rates allow for rapid treatment. The initialtarget markets for Accolade will include Japan, Korea and China, where dermallesions such as Nevus of Ota and Nevus of Ito are common.

"Given the market potential for this technology, particularly in the AsiaPacific region, we are excited about the prospects for Accolade," Davin said."As a flagship product, Accolade is expected to generate a minimum of $10million in revenue in its first full year on the market."

Affirm Er -- Ablative Skin Resurfacing with Minimal Downtime

Cynosure's new Affirm Er is a 2940 nm wavelength, Erbium: YAG laser forablative skin resurfacing applications, such as the treatment of deep linesand wrinkles. The Affirm Er handpiece is designed as a complementary fourthwavelength for the Affirm Anti-Aging workstation, Cynosure's award-winningplatform for anti-aging applications

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store